BRIEF—Bayer offers more concessions for Monsanto bid

German pharma and crop sciences major Bayer has offered concessions to allay European Union antitrust concerns about its $63.5 billion bid for US agri-chemical and seed rival Monsanto announced in September 2016, according to the European Commission, extending its investigation of the deal to April 5, according to a Reuters report.

Bayer and the European Commission have not given any further details of the concessions offered.

Bayer has previously struck a deal with BASF in October 2017 to sell seed and herbicide businesses for 5.9 billion euros ($7.3 billion), but it's prepared to do more to gain EU approval.